Biotech Support

Biotech Support

To promote commercialization and industrialization in the fields of regenerative medicine and cell therapy, which are expected to experience significant growth, KSP provides hands-on support through incubation managers based at KSP Biotech Lab.

In addition, KSP carries out the Regenerative Medicine and Cell Therapy Industrialization Promotion Program commissioned by Kanagawa Prefecture, providing support through the Regenerative medicine & cell therapy Industrialization Network of Kanagawa (RINK) and the Regenerative Medicine and Cell Therapy Industrialization Joint Project.

Cooperation with Kanagawa Prefecture (Commissioned Projects)

“Regenerative Medicine and Cell Therapy Industrialization Joint Project”

By supporting regenerative medicine and cell therapy projects (research, development and commercialization) conducted by startups etc. within the prefecture, Kanagawa Prefecture seeks to facilitate early and reliable commercialization within its borders and to create networking effects in related industries. To this end, Kanagawa Prefecture implements a program to promote the industrialization of regenerative medicine and cell therapy.

KSP has been commissioned by Kanagawa Prefecture to implement this program and, as part of the program, carries out the Regenerative Medicine and Cell Therapy Industrialization Joint Project. This project identifies promising new research and technology opportunities in regenerative medicine and cell therapy, mainly from startup companies and researchers within Kanagawa Prefecture. KSP, Inc. undertakes joint projects with the applicants to promote commercialization and industrialization in this field.

In addition to covering part of the project expenses related to commercialization, KSP provides support by researching market needs and developing sales channels.

Details of support
– Support for expenses in relation to the promotion of projects (expenses leading to promotion of commercialization)
– Hands-on support aimed at commercialization (researching needs, opening sales channels, preparing operating bases etc.)

Targeted projects
Projects implemented by companies (including those to be established) with a base for research and other operations in Japan, provided that the projects meet all of the following criteria:
– The project concerns regenerative medicine and cell therapy or related fields.
– The project aims to carry out trial production or commercialization of products in Kanagawa Prefecture.
– The project demonstrates particular merit in terms of business feasibility or technology.

Regenerative medicine & Cell therapy industrialization network of Kanagawa (RINK)

The Regenerative medicine & Cell therapy industrialization network of Kanagawa (RINK) was established to actively participate in and cooperate with a variety of related industry bodies, institutions, companies and academic institutions, primarily for the benefit of tenant companies of the Life Innovation Center, located in the King Skyfront area.

RINK’s goal is to promote cooperation and collaboration among companies, academic institutions and other organizations involved in research and development or commercialization in regenerative medicine and cell therapy, with the aim of accelerating the industrialization of the field.

Going forward, to achieve our ultimate goal to build a chain of processes (value chain) consisting of cell processing, cultivation, evaluation, storage and transport, we will work to expand the organization and to broaden and further energize its activities.